Galunisertib
In Stock•Starting at $11 for 1 mg•Purity ≥ 98%
| CAS No. | 700874-72-2 |
|---|---|
| MDL No. | N/A |
| MF | C22H19N5O |
| MW | 369.40 |
| InChI Key | IVRXNBXKWIJUQB-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $11 | In Stock | |
| 10 mg | 98% | $14 | In Stock | |
| 25 mg | 98% | $32 | In Stock | |
| 50 mg | 98% | $43 | In Stock | |
| 100 mg | 98% | $76 | In Stock |
Product Information
LY-2157299 is a pyrrolopyrazole compound with the structure of 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole. It is substituted at position 2 with a 6-methylpyridin-2-yl group and at position 3 with a 6-(aminocarbonyl)quinolin-4-yl group. It is a TGF-betaRI kinase inhibitor that blocks TGF-beta-mediated tumor growth in glioblastoma. It functions as a TGFbeta receptor antagonist and antineoplastic agent. It belongs to quinolines, pyrrolopyrazoles, methylpyridines, aromatic amides, and monocarboxylic acid amides.
| CAS No. | 700874-72-2 |
|---|---|
| Product Name | Galunisertib |
IrritantSignal Word:Warning
HCode:H315-H319-H335
PCode:P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501
